RSC Publishing


Publishing

 

Cover image for Dalton Transactions, select for current issue

Dalton Transactions

The international journal for inorganic, organometallic and bioinorganic chemistry



Canadian Society for Chemistry award presented to Dalton Transactions Chair


08 June 2008

Congratulations to Professor Chris Orvig, Chair of the Dalton Transactions  Editorial Board, on his recent Canadian Society for Chemistry award.

Chris Orvig was presented with the Rio Tinto Alcan Award at the 92nd Canadian Chemistry Conference and Exhibition in Hamilton, Canada last week. The prize is awarded to a scientist, who has made a distinguishing contribution in the fields of inorganic chemistry or electrochemistry while working in Canada. 

Chris Orvig, FCIC, was born and raised in Montréal.  He received his Hons. BSc in chemistry from McGill University in 1976 and subsequently completed his doctorate (as a Natural Sciences and Engineering Research Council - NSERC - of Canada scholar) in technetium chemistry at MIT with Alan Davison, FRS.  After an NSERC postdoctoral fellowship with Kenneth N. Raymond at the University of California, Berkeley (1981-1983) and one year with the late Colin J. L. Lock at McMaster University, he joined the Department of Chemistry at the University of British Columbia in 1984, where he is now professor of chemistry and pharmaceutical sciences, and director of the Medicinal Inorganic Chemistry Group, as well as graduate advisor.  His scientific interests are firmly based in the areas of medicinal inorganic chemistry and coordination chemistry - he has been involved over the years with radiopharmaceutical chemistry, metal ion decorporation, and metal ion neurotoxicology, as well as chemotherapeutic metal complexes and ligands.  Chris has been the Chair of the Dalton Transactions Editorial Board since January 2008.  

Professor Chris Orvig

 

 

 

 

Also of interest

Glycosylated tetrahydrosalens as multifunctional molecules for Alzheimer's therapy
Tim Storr, Lauren E. Scott, Meryn L. Bowen, David E. Green, Katherine H. Thompson, Harvey J. Schugar and Chris Orvig, Dalton Trans., 2009, 3034
DOI: 10.1039/b902545f


Altering pyridinone N-substituents to optimise activity as potential prodrugs for Alzheimer's disease
Lauren E. Scott, Brent D. G. Page, Brian O. Patrick and Chris Orvig, Dalton Trans., 2008, 6364
DOI: 10.1039/b815404j


Lanthanide containing compounds for therapeutic care in bone resorption disorders
Cheri A. Barta, Kristina Sachs-Barrable, Jessica Jia, Katherine H. Thompson, Kishor M. Wasan and Chris Orvig, Dalton Trans., 2007, 5019
DOI: 10.1039/b705123a